ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹637 Cr | ₹625 Cr | ₹604 Cr | ₹512 Cr | ₹475 Cr |
What is the latest Total Liabilities ratio of ALBERT DAVID ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹637 Cr |
| Mar2025 | ₹625 Cr |
| Mar2024 | ₹604 Cr |
| Mar2023 | ₹512 Cr |
| Mar2022 | ₹475 Cr |
How is Total Liabilities of ALBERT DAVID Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹637 Cr | 1.93 | |
| Mar2025 | ₹625 Cr | 3.34 | |
| Mar2024 | ₹604 Cr | 17.98 | |
| Mar2023 | ₹512 Cr | 7.82 | |
| Mar2022 | ₹475 Cr | - | |
Compare Total Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹437.9 Cr | -4.5% | -12.8% | -4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.1% | -6.5% | 3.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,780.0 Cr | -0.2% | -5.5% | 35.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,828.0 Cr | 0.4% | -8.2% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,305.0 Cr | 1.7% | -2% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,759.0 Cr | 4.9% | 7.7% | -2.5% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -4.5% |
-12.8% |
-4% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
You may also like the below Video Courses